Cipher Pharmaceuticals (OTCMKTS:CPHRF) Shares Cross Above Fifty Day Moving Average of $10.24

Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF) (TSE:CPH)’s share price crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $10.24 and traded as high as $11.00. Cipher Pharmaceuticals shares last traded at $10.67, with a volume of 22,438 shares traded.

Cipher Pharmaceuticals Trading Down 3.5 %

The stock’s fifty day moving average price is $10.24 and its two-hundred day moving average price is $7.65.

Cipher Pharmaceuticals Company Profile

Cipher Pharmaceuticals Inc operates as a specialty pharmaceutical company in Canada. It offers Epuris (isotretinoin), an oral retinoid indicated for the treatment of severe nodular and/or inflammatory acne, acne conglobate, and recalcitrant acne; Actikerall, a topical solution indicated for the treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis (Grade I/II) of the face, forehead, and balding scalp; Ozanex for the topical treatment of impetigo; Vaniqa, a topical cream for the slowing of the growth of unwanted facial hair in women; Durela, an opioid analgesic for the management of moderate to moderately severe pain in adults; Brinavess for the rapid conversion of onset atrial fibriallation to sinus rhythm in adults; and Aggrastat, a reversible GP IIb/IIIa inhibitor for use in patients with Acute Coronary Syndrome.